Literature DB >> 30363955

Readmissions in adult patients following hospitalization for influenza: a nationwide cohort study.

Srikanth Yandrapalli1, Wilbert S Aronow1, William H Frishman1.   

Abstract

BACKGROUND: Influenza epidemics are a major health care concern in the US. Influenza related complications can increase in-hospital complications, and readmissions following a hospitalization for influenza. We sought to determine the 30-day readmission rate, etiologies, outcomes, and healthcare burden of 30-day readmissions in adults hospitalized for influenza.
METHODS: The 2014 US National Readmissions Database (NRD) was retrospectively analyzed to identify patients ≥18 years of age hospitalized for influenza and discharged between January and November 2014. We used this time frame as this was the most recent data available for analysis and included patients who had 30-day follow-up. Survey design based multivariable logistic regression models were used to identify factors associated with a 30-day readmission.
RESULTS: Of the 46,117 patients who were hospitalized for influenza and survived to discharge, 4,721 (10.2%) patients had 5,275 30-day readmissions, estimated to 11.4 readmissions per 100 patients. Non-influenza pneumonia was the most common etiology of 30-day readmissions (10.4%) followed by sepsis (9.8%). The median costs of readmissions were $8,538 (IQR, $5,053-15,262), which were significantly higher than the median costs of their index hospitalizations [$7,863 (IQR, $4,875-13,212); P<0.001]. Around 6.5% of the patients died during a readmission.
CONCLUSIONS: Adult patients hospitalized for influenza had 11.4 30-day readmissions per 100 patients, most commonly for non-influenza pneumonia. Thirty-day readmissions were associated with higher costs of care and considerable mortality.

Entities:  

Keywords:  Influenza; acute myocardial infarction (AMI); pneumonia; readmissions; stroke

Year:  2018        PMID: 30363955      PMCID: PMC6186976          DOI: 10.21037/atm.2018.07.18

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  17 in total

Review 1.  Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies.

Authors:  Mohammad Madjid; Morteza Naghavi; Silvio Litovsky; S Ward Casscells
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Authors:  Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

3.  Temporal relationship between influenza infections and subsequent first-ever stroke incidence.

Authors:  André M Toschke; Peter U Heuschmann; Oliver Wood; Charles D A Wolfe
Journal:  Age Ageing       Date:  2008-11-21       Impact factor: 10.668

Review 4.  Influenza and stroke risk: a key target not to be missed?

Authors:  Christian Urbanek; Frederick Palm; Armin J Grau
Journal:  Infect Disord Drug Targets       Date:  2010-04

5.  Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure.

Authors:  C Sandoval; S D Walter; P Krueger; M Smieja; A Smith; S Yusuf; M B Loeb
Journal:  Epidemiol Infect       Date:  2006-08-29       Impact factor: 2.451

6.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.

Authors:  Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

7.  Acute myocardial infarction and influenza: a meta-analysis of case-control studies.

Authors:  Michelle Barnes; Anita E Heywood; Abela Mahimbo; Bayzid Rahman; Anthony T Newall; C Raina Macintyre
Journal:  Heart       Date:  2015-08-26       Impact factor: 5.994

Review 8.  Influenza infection and COPD.

Authors:  Patrick Mallia; Sebastian L Johnston
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 9.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review.

Authors:  Charlotte Warren-Gash; Liam Smeeth; Andrew C Hayward
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

Review 10.  Virus-induced exacerbations in asthma and COPD.

Authors:  Daisuke Kurai; Takeshi Saraya; Haruyuki Ishii; Hajime Takizawa
Journal:  Front Microbiol       Date:  2013-10-01       Impact factor: 5.640

View more
  5 in total

1.  Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19.

Authors:  Parag Goyal; Evgeniya Reshetnyak; Sadiya Khan; Mahad Musse; Babak B Navi; Jiwon Kim; Larry A Allen; Samprit Banerjee; Mitchell S V Elkind; Sanjiv J Shah; Clyde Yancy; Erin D Michos; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Monika M Safford
Journal:  Circ Heart Fail       Date:  2021-09-14       Impact factor: 10.447

2.  (-)-Epigallocatechin-3-gallate induces interferon-λ2 expression to anti-influenza A virus in human bronchial epithelial cells (BEAS-2B) through p38 MAPK signaling pathway.

Authors:  Jie Zhu; Li Ou; Yongjun Zhou; Zixiao Yang; Mingjiang Bie
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

3.  Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.

Authors:  Colin Pawlowski; A J Venkatakrishnan; Eshwan Ramudu; Christian Kirkup; Arjun Puranik; Nikhil Kayal; Gabriela Berner; Akash Anand; Rakesh Barve; John C O'Horo; Andrew D Badley; Venky Soundararajan
Journal:  EClinicalMedicine       Date:  2021-03-23

Review 4.  The economic burden of influenza among adults aged 18 to 64: A systematic literature review.

Authors:  Caroline de Courville; Sarah M Cadarette; Erika Wissinger; Fabián P Alvarez
Journal:  Influenza Other Respir Viruses       Date:  2022-02-05       Impact factor: 4.380

5.  Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.

Authors:  Shima Shahjouei; Soheil Naderi; Jiang Li; Ayesha Khan; Durgesh Chaudhary; Ghasem Farahmand; Shailesh Male; Christoph Griessenauer; Mirna Sabra; Stefania Mondello; Achille Cernigliaro; Faezeh Khodadadi; Apoorva Dev; Nitin Goyal; Sakineh Ranji-Burachaloo; Oluwaseyi Olulana; Venkatesh Avula; Seyed Amir Ebrahimzadeh; Orkhan Alizada; Mehmet Murat Hancı; Askar Ghorbani; Alaleh Vaghefi Far; Annemarei Ranta; Martin Punter; Mahtab Ramezani; Nima Ostadrahimi; Georgios Tsivgoulis; Paraskevi C Fragkou; Peyman Nowrouzi-Sohrabi; Emmanouil Karofylakis; Sotirios Tsiodras; Saeideh Neshin Aghayari Sheikh; Alia Saberi; Mika Niemelä; Behnam Rezai Jahromi; Ashkan Mowla; Mahsa Mashayekhi; Reza Bavarsad Shahripour; Seyed Aidin Sajedi; Mohammad Ghorbani; Arash Kia; Nasrin Rahimian; Vida Abedi; Ramin Zand
Journal:  EBioMedicine       Date:  2020-08-17       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.